Abnormal NMDA receptor function exacerbates experimental autoimmune encephalomyelitis
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Background and Purpose: Glutamate transmission is dysregulated in both multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE), the animal model of MS. A characteristic of EAE is increased glutamate transmission associated with up‐regulation of AMPA receptors. However, little is known about the role of NMDA receptors in the synaptic modifications induced by EAE. Experimental Approach: The contribution of NMDA receptors to the alterations of glutamate transmission and disease severity in EAE mice was assessed by means of neurophysiological, morphological, Western blot, metabolic and clinical score assessments. Key Results: I n our EAE mice, there was an NMDA receptor‐dependent increase of glutamate release, associated with marked activation of the astroglia. Presynaptic NMDA receptors became overactive during EAE, increasing synaptic glutamate release by a mechanism dependent on voltage‐gated sodium channels. By means of NAD(P)H autofluorescence analysis, we also found that EAE has a glutamate and NMDA receptor‐dependent dysfunction of mitochondrial activity, which is known to contribute to the neurodegenerative damage of MS and EAE. Furthermore, pharmacological blockade of NMDA receptors in vivo ameliorated both synaptic transmission defects and of the clinical disease course of EAE mice, while EAE induced in mice with a genetically enhanced NMDA receptor signalling had opposite effects. Conclusions and Implications: Our data, showing both sensitization of NMDA receptors and their involvement in the progression of the EAE disease, supggest that pharmacological impairment of NMDA receptor signalling would be a component of a neuroprotection strategy in MS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guide to receptors and channels (GRAC), 5th edition
Alexander, S., Mathie, A., & Peters, J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01649_1.x · Cited by 1,947 · cited 1×
“While the role of these receptors has been investigated in these studies, little is known about the potential involvement of NMDA receptors in EAE pathophysiology (receptor nomenclature follows Alexander et al., 2011).”
BackgroundGuidelines for reporting experiments involving animals: the ARRIVE guidelines
McGrath, J., Drummond, G., McLachlan, E., Kilkenny, C., & Wainwright, C. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00873.x · Cited by 1,592
Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury
Arundine, M., & Tymianski, M. (2004) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-003-3319-x · Cited by 647
Alternative excitotoxic hypotheses
Albin, R. L., & Greenamyre, J. T. (1992) · Neurology · doi:10.1212/wnl.42.4.733 · Cited by 574 · cited 2×
“Glutamate toxicity has in fact been proposed as the basis of the pathogenesis of ischaemic brain damage (Arundine and Tymianski, 2004) and of several neurodegenerative diseases, including Alzheimer’s disease, Huntington’s disease, Parkinson’s disease, amyotrophic lateral sclerosis (Albin and Greenamyre, 1992) and mult…”
BackgroundMitochondrial defects in acute multiple sclerosis lesions
Mahad, D., Ziabreva, I., Lassmann, H., & Turnbull, D. (2008) · Brain · doi:10.1093/brain/awn105 · Cited by 406 · cited 2×
“Mitochondrial dysfunction has been recently proposed to contribute significantly to neurodegenerative damage in MS (Kalman et al., 2007; Mahad et al., 2008; Witte et al., 2010; Campbell et al., 2011) and in EAE (Qi et al.”
BackgroundCentonze, D., Muzio, L., Rossi, S., Cavasinni, F., De Chiara, V., Bergami, A., Musella, A., D'Amelio, M., Cavallucci, V., Martorana, A., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5804-08.2009 · Cited by 390 · cited 24×
“Although the great majority of proliferating cells detected within striatum belonged to the microglia/macrophage lineage (Centonze et al., 2009), approximately 17% of GFAP-expressing cells in EAE brains incorporated the IdU tracer, suggesting that reactive astrocytes increase their number during…”
BackgroundMethodResultInfluentialSelf-citationNAD(P)H fluorescence imaging of postsynaptic neuronal activation in murine hippocampal slices
Shuttleworth, C. W., Brennan, A. M., & Connor, J. A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-08-03196.2003 · Cited by 151 · cited 3×
“Mitochondrial NADH dynamics are predominant contributors to both phases of evoked NAD(P)H transient signals (Schuchmann et al., 2001; Shuttleworth et al., 2003; Brennan et al., 2006; 2007) and were reduced in our EAE model, confirming severe impairment of mitochondrial activity in this disorder (Qi…”
BackgroundPohl, H. B. F., Porcheri, C., Mueggler, T., Bachmann, L. C., Martino, G., Riethmacher, D., Franklin, R. J. M., Rudin, M., & Suter, U. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.5035-10.2011 · Cited by 145
Self-citationImpaired striatal GABA transmission in experimental autoimmune encephalomyelitis
Rossi, S., Muzio, L., De Chiara, V., Grasselli, G., Musella, A., Musumeci, G., Mandolesi, G., De Ceglia, R., Maida, S., Biffi, E., et al. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.10.004 · Cited by 112 · cited 9×
“Excessive synaptic excitation by the neurotransmitter glutamate triggers neuronal damage in acute and chronic neurological disorders, including EAE and MS (Forder and Tymianski, 2009; Rossi et al., 2011).”
BackgroundMethodResultInfluentialSelf-citationBrennan, A. M., Connor, J. A., & Shuttleworth, C. W. (2006) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600292 · Cited by 97 · cited 2×
“…NADH dynamics are predominant contributors to both phases of evoked NAD(P)H transient signals (Schuchmann et al., 2001; Shuttleworth et al., 2003; Brennan et al., 2006; 2007) and were reduced in our EAE model, confirming severe impairment of mitochondrial activity in this disorder (Qi et al.,…”
Background
Cited by
Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0
Percie du Sert, N., Ahluwalia, A., Alam, S., Avey, M. T., Baker, M., Browne, W. J., Clark, A., Cuthill, I. C., Dirnagl, U., Emerson, M., et al. (2020) · PLOS Biology · doi:10.1371/journal.pbio.3000411 · Cited by 2,677
“‘In the study, n refers to number of animals, with five acquisitions from each [corticostriatal] slice, with a maximum of three slices obtained from each experimental animal used for each protocol (six animals each group)’ [31].”
MethodMechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis
Friese, M. A., Schattling, B., & Fugger, L. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.37 · Cited by 628
Reporting animal research: Explanation and Elaboration for the ARRIVE guidelines 2019
Percie du Sert, N., Ahluwalia, A., Alam, S., Avey, M. T., Baker, M., Browne, W. J., Clark, A., Cuthill, I. C., Dirnagl, U., Emerson, M., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/703355 · Cited by 559
Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis
Mandolesi, G., Gentile, A., Musella, A., Fresegna, D., De Vito, F., Bullitta, S., Sepman, H., Marfia, G. A., & Centonze, D. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.222 · Cited by 286
Self-citationGuadalupi, L., Mandolesi, G., Vanni, V., Balletta, S., Caioli, S., Pavlovic, A., De Vito, F., Fresegna, D., Sanna, K., Vitiello, L., et al. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.109940 · Cited by 22
“Finally, by performing GFAP immunostaining, we investigated for the first time the effect of MAGLi treatment on striatal astrogliosis, an event markedly associated with EAE induction (Grasselli et al., 2013) (Fig.”
Self-citation
Metadata
- Authors
- Grasselli, G., Rossi, S., Musella, A., Gentile, A., Loizzo, S., Muzio, L., Di Sanza, C., Errico, F., Musumeci, G., Haji, N., Fresegna, D., Sepman, H., De Chiara, V, Furlan, R., Martino, G., Usiello, A., Mandolesi, G., & Centonze, D.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2012-12-20
- Volume
- 168
- Issue
- 2
- Pages
- 502-517
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1587172615
- Cited by
- 47
- References
- 11
- FWCI
- 1.68
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Abnormal NMDA receptor function exacerbates experimental autoimmune encephalomyelitis. https://app.cochat.ai/papers/10.1111/j.1476-5381.2012.02178.x
- The paper
- Grasselli, G., Rossi, S., Musella, A., Gentile, A., Loizzo, S., Muzio, L., Di Sanza, C., Errico, F., Musumeci, G., Haji, N., Fresegna, D., Sepman, H., De Chiara, V, Furlan, R., Martino, G., Usiello, A., Mandolesi, G., & Centonze, D. (2013). Abnormal NMDA receptor function exacerbates experimental autoimmune encephalomyelitis. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.2012.02178.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.